About RetinaRisk
RetinaRisk is a company based in Reykjavik (Iceland) founded in 2013.. RetinaRisk has raised $1.8 million across 1 funding round. RetinaRisk offers products and services including RetinaRisk iClinic and RetinaRisk API. RetinaRisk operates in a competitive market with competitors including BaseHealth, Advance Health, Peach IntelliHealth, PeraHealth and ToLife, among others.
- Headquarter Reykjavik, Iceland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.8 M (USD)
in 1 rounds
-
Latest Funding Round
$1.8 M (USD), Seed
Jan 01, 2021
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RetinaRisk
RetinaRisk offers a comprehensive portfolio of products and services, including RetinaRisk iClinic and RetinaRisk API. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Web-based tool for diabetic eye care risk assessment and screening.
Interface for accessing risk algorithms in healthcare systems.
Funding Insights of RetinaRisk
RetinaRisk has successfully raised a total of $1.8M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.8 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.8M
-
First Round
First Round
(01 Jan 2021)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Seed - RetinaRisk | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by RetinaRisk
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RetinaRisk
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Retinarisk Comparisons
Competitors of RetinaRisk
RetinaRisk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BaseHealth, Advance Health, Peach IntelliHealth, PeraHealth and ToLife, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomics-driven personalized health risks and recommendations are provided.
|
|
| domain | founded_year | HQ Location |
Provider of health risk assessments and care management solutions for providers
|
|
| domain | founded_year | HQ Location |
An AI-based platform is provided to predict patient trajectories.
|
|
| domain | founded_year | HQ Location |
Patient conditions are tracked in real-time for hospital care applications.
|
|
| domain | founded_year | HQ Location |
Emergency care management software is provided for hospitals.
|
|
| domain | founded_year | HQ Location |
AI-based disease prediction is offered to healthcare professionals.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Retinarisk
Frequently Asked Questions about RetinaRisk
When was RetinaRisk founded?
RetinaRisk was founded in 2013 and raised its 1st funding round 8 years after it was founded.
Where is RetinaRisk located?
RetinaRisk is headquartered in Reykjavik, Iceland.
Is RetinaRisk a funded company?
RetinaRisk is a funded company, having raised a total of $1.8M across 1 funding round to date. The company's 1st funding round was a Seed of $1.8M, raised on Jan 01, 2021.
What does RetinaRisk do?
RetinaRisk is a decision support system for the management and follow-up of patients with diabetes or diabetic retinopathy offered by Risk Medical Solutions (RMS). It allows doctors to educate patients demonstrating how the improvement of modifiable risk factors like blood glucose, HbA1c, and blood pressure, etc. may significantly lower the risk of diabetic eye diseases. The platform also provides health risk assessment solutions for patients.
Who are the top competitors of RetinaRisk?
RetinaRisk's top competitors include UCARE.AI, BaseHealth and Peach IntelliHealth.
What products or services does RetinaRisk offer?
RetinaRisk offers RetinaRisk iClinic and RetinaRisk API.